Although single treatment with gefitinib alone showed no significant effects, possibly because A549 cells were EGFR wild-type cells, combining JNJ-38877605 with gefitinib suppressed tumour growth significantly more than JNJ-38877605 alone. This evidence concerns the gene EGFR and neoplasm.